Long-Term Outcome of Pediatric Patients with Severe Aplastic Anemia Treated with Antithymocyte Globulin and Cyclosporine

Journal of Pediatrics

Volumn 153, Issue 6, 2008, Pages

  Scheinberg, Phillip ^a   Wu, Colin O ^a   Nunez, Olga ^a   Young, Neal S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; THYMOCYTE ANTIBODY;

APLASTIC ANEMIA; ARTICLE; BONE MARROW BIOPSY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 56049083968     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2008.06.004     Document Type: Article

References (25)

1. Alter B.P., and Young N.S. The bone marrow failure syndromes. In: Nathan D.G., and Orkin S.H. (Eds). Nathan and Oski's Hematology of Infancy and Childhood. 5th ed. (1998), WB Saunders, Philadelphia 237-335
2. Fogarty P.F., Yamaguchi H., Wiestner A., Baerlocher G.M., Sloand E.M., Zeng W., et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet 362 (2003) 1628-1630
3. Gillio A.P., Verlander P.C., Batish S.D., Giampietro P.F., and Auerbach A.D. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Blood 90 (1997) 105-110
4. Yamaguchi H., Calado R.T., Ly H., Baerlocher G.M., Kajigaya S., Chanock S.J., et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N Eng J Med 352 (2005) 1413-1424
5. Horowitz M.M. Current status of allogeneic bone marrow transplantation in acquired aplastic anemia. Semin Hematol 37 (2000) 30-42
6. Ades L., Mary J.Y., Robin M., Ferry C., Porcher R., Esperou H., et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 103 (2004) 2490-2497
7. Frickhofen N., and Rosenfeld S.J. Immunosuppressive treatment of aplastic anemia with antithymocyte globuilin and cyclosporine. Semin Hematol 37 (2000) 56-68
8. Rosenfeld S., Follman D., Nunez O., and Young N.S. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 289 (2003) 1130-1135
9. Scheinberg P., Nunez O., Wu C., and Young N.S. Treatment of severe aplastic anemia with combined immunosuppression: antithymocyte globulin (ATG), cyclosporin A (CSA), and mycophenolate mofetil (MMF). Br J Haematol 133 (2006) 606-611
10. Rosenfeld S.J., Kimball J., Vining D., and Young N.S. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 85 (1995) 3058-3065
11. Dunn D.E., Tanawattanacharoen P., Boccuni P., Nagakura S., Green S.W., Kirby M.R., et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med 131 (1999) 401-408
12. Bayever E., Champlin R., Ho W., Lenarsky C., Storch S., Ladisch S., et al. Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia. J Pediatr 105 (1984) 920-925
13. Halperin D.S., Grisaru D., Freedman M.H., and Saunders E.F. Severe acquired aplastic anemia in children: 11-year experience with bone marrow transplantation and immunosuppressive therapy. Am J Pediatr Hematol Oncol 11 (1989) 304-309
14. Locasciulli A., van't Veer L., Bacigalupo A., Hows J., van Lint M.T., Gluckman E., et al. Treatment with marrow transplantation or immunosuppression of childhood-acquired severe aplastic anemia: a report from the EBMT SAA working party. Bone Marrow Transplant 6 (1990) 211-217
15. Gillio A.P., Boulad F., Small T.N., Kernan N.A., Reyes B., Childs B.H., et al. Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation. Biol Blood Marrow Transplant 5 (1997) 18-24
16. Fuhrer M., Burdach S., Ebell W., Gadner H., Haas R., Harbott J., et al. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. Klinische Padiatrie 210 (1998) 173-179
17. Kojima S., Hibi S., Kosaka Y., Yamamoto M., Tsuchida M., Mugishima H., et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 96 (2000) 2049-2054
18. Kennedy-Nasser A.A., Leung K.S., Mahajan A., Weiss H.L., Arce J.A., Gottschalk S., et al. Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia. Biol Blood Marrow Transplant 12 (2006) 1277-1284
19. Kojima S., Matsuyama T., Kato S., Kigasawa H., Kobayashi R., Kikuta A., et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood 100 (2002) 799-805
20. Passweg J.R., Pérez W.S., Eapen M., Camitta B.M., Gluckman E., Hinterberger W., et al. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant 37 (2006) 641-649
21. Locasciulli A., Oneto R., Bacigalupo A., Socie G., Korthof E., Bekassy A., et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation. Haematologica 92 (2007) 11-18
22. Bacigalupo A., Locatelli F., Lanino E., Marsh J., Socie G., Maury S., et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor tranplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 36 (2005) 947-950
23. Deeg H.J., O'Donnell M., Tolar J., Agarwal R., Harris R.E., Feig S.A., et al. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 108 (2006) 1485-1491
24. Young N.S., Calado R.T., and Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108 (2006) 2509-2519
25. Fuhrer M., Rampf U., Baumann I., Faldum A., Niemeyer C., Janka-Schaub G., et al. Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood 106 (2005) 2102-2104